Marksans Pharma Ltd.
BSE: 524404 | Sector: Health care |
NSE: MARKSANS | ISIN Code: INE750C01026 |
BSE 00:00 | 01 Jul | 43.45 |
-0.25 (-0.57%) |
OPEN
43.40 |
HIGH
44.55 |
LOW
43.25 |
NSE 00:00 | 01 Jul | 43.50 |
-0.10 (-0.23%) |
OPEN
44.25 |
HIGH
44.70 |
LOW
43.20 |
OPEN | 43.40 |
PREVIOUS CLOSE | 43.70 |
VOLUME | 57604 |
52-Week high | 93.50 |
52-Week low | 38.70 |
P/E | 17.11 |
Mkt Cap.(Rs cr) | 1,778 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Marksans Pharma Ltd.
Marksans Pharma Limited is a public limited company incorporated in the year April 16th 1982. The Company is primarily engaged in the business of research manufacture marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna Goa and R & D center in Navi Mumbai.The Company on 30th March 2015 issued and allotted 24006494 equity shares of...> More
Marksans Pharma Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
1,778 | |
EPS - TTM | (![]() |
[*S] | 2.54 |
P/E Ratio | (X) | [*S] | 17.11 |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | 25.00 | |
Latest Dividend Date | 15 Sep 2021 | ||
Dividend Yield | (%) | 0.58 | |
Book Value / Share | (![]() |
[*S] | 19.17 |
P/B Ratio | (![]() |
[*S] | 2.27 |
Announcement
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
-
Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Dis
Marksans Pharma Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 418.04 | 330.2 | 26.6 |
Other Income | 15.34 | 6.01 | 155.24 |
Total Income | 433.39 | 336.21 | 28.9 |
Total Expenses | 354.4 | 234.83 | 50.92 |
Operating Profit | 78.98 | 101.39 | -22.1 |
Net Profit | 29.65 | 79.5 | -62.7 |
Equity Capital | 40.93 | 40.93 | - |
Marksans Pharma Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Morepen Labs. | 38.00 | -1.81 | 1896.77 |
Dishman Carbogen | 117.50 | 3.66 | 1842.40 |
Hester Bios | 2162.20 | 1.80 | 1840.03 |
Marksans Pharma | 43.45 | -0.57 | 1778.41 |
Unichem Labs. | 241.45 | -0.43 | 1699.81 |
Novartis India | 671.30 | 9.57 | 1658.11 |
Alembic | 62.50 | 0.00 | 1605.00 |
Marksans Pharma Ltd - SHAREHOLDING PATTERN
|
|
Marksans Pharma Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 4.57% | 4.57% | 0.34% | 0.34% |
1 Month | -7.06% | -7.05% | -4.47% | -4.66% |
3 Month | -17.08% | -16.91% | -10.74% | -10.86% |
6 Month | -27.64% | -27.68% | -9.18% | -9.23% |
1 Year | -49.36% | -49.36% | 1.13% | 0.46% |
3 Year | 111.95% | 112.71% | 33.31% | 32.75% |
Marksans Pharma Ltd - STOCK STRENGTH
Today's Low/High | 43.25 | 44.55 | |
Week Low/High | 40.35 | 47.00 | |
Month Low/High | 38.70 | 48.00 | |
YEAR Low/High | 38.70 | 94.00 | |
All TIME Low/High | 0.71 | 115.00 |
Quick Links for Marksans Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices